Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Cancer Research

• Publication date

  1981-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 7214320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Medicine

  1982cited by this paper
• Liposomal protection of adriamycin-induced cardiotoxicity in mice.

  1980cited by this paper
• Factors affecting the encapsulation of drugs within liposomes.

  1979cited by this paper
• Chemical interactions of cardiolipin with daunorubicin and other intercalating agents.

  1979cited by this paper
• In vitro and in vivo studies with adriamycin liposomes.

  1979cited by this paper
• Uptake of liposome-entrapped mannitol by diaphragm.

  1979cited by this paper
• Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.

  1979cited by this paper
• EFFECTS OF ENTRAPMENT IN LIPOSOMES ON THE DISTRIBUTION, DEGRADATION AND EFFECTIVENESS OF METHOTREXATE IN VIVO

  1978cited by this paper
• Effect of lipid vesicle (liposome) encapsulation of methotrexate on its chemotherapeutic efficacy in solid rodent tumors.

  1978cited by this paper
• Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

  1978cited by this paper
• PROPERTIES AND BIOLOGICAL EFFECTS OF LIPOSOMES AND THEIR USES IN PHARMACOLOGY AND TOXICOLOGY

  1978cited by this paper
• Adriamycin: a proposal on the specificity of drug action.

  1978cited by this paper
• Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.

  1978cited by this paper
• PHARMACOKINETICS OF LIPOSOME‐ENCAPSULATED ANTITUMOR DRUGS AND IMPLICATIONS FOR THERAPY *

  1978cited by this paper
• A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayers.

  1978cited by this paper
• POTENTIAL APPLICATIONS OF LIPOSOMES TO THERAPY *

  1978cited by this paper
• Characterization of drug-membrane interactions using the liposome system.

  1977cited by this paper
• Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response.

  1977cited by this paper
• The carrier potential of liposomes in biology and medicine (first of two parts).

  1976cited by this paper
• Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.

  1976cited by this paper
• The carrier potential of liposomes in biology and medicine (second of two parts).

  1976cited by this paper
• Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles.

  1976cited by this paper
• Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival.

  1975cited by this paper
• Enhancement of the cancer chemotherapeutic effect of cytosine arabinoside entrapped in liposomes on mouse leukemia L-1210.

  1975cited by this paper
• The entry of foreign compounds into the thoracic duct lymph of the rat.

  1974cited by this paper
• Liposome-Encapsulated Actinomycin D: Potential in Cancer Chemotherapy 1

  1974cited by this paper
• Morphological observations on the cellular and subcellular destination of intravenously administered liposomes.

  1974cited by this paper
• Adriamycin and daunorubicin disposition in the rabbit.

  1974cited by this paper
• Preparation and Use of Liposomes as Models of Biological Membranes

  1974cited by this paper
• An Evaluation of Ten Pairwise Multiple Comparison Procedures by Monte Carlo Methods

  1973cited by this paper
• Experimental studies on lymphatic drainage of the peritoneal cavity using 198Au-colloid.

  1973cited by this paper
• Role of the lymphatics in the intestinal absorption and distribution of drugs.

  1969cited by this paper
• Lymphatics and Lymph Circulation

  1968cited by this paper
• Diffusion of univalent ions across the lamellae of swollen phospholipids.

  1965cited by this paper
• THE LYMPHATIC PATHWAYS FROM THE PERITONEAL CAVITY: A LYMPHANGIOGRAPHIC STUDY IN THE RAT.

  1964cited by this paper

• Entry and exit of extracellular vesicles to and from the blood circulation

  2023cites this paper
• Effects of particle size and release property of paclitaxel-loaded nanoparticles on their peritoneal retention and therapeutic efficacy against mouse malignant ascites.

  2022cites this paper
• Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma

  2019cites this paper
• Peyer’s Patch: Targeted Drug Delivery for Therapeutics Benefits

  2019cites this paper
• Nanoparticles in detection and treatment of lymph node metastases: an update from the point of view of administration routes

  2018cites this paper
• Recent Advances in the Delivery of Chemotherapeutic Agents

  2017cites this paper
• Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis

  2017cites this paper
• Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy.

  2016cites this paper
• Docetaxel Accumulates in Lymphatic Circulation Following Subcutaneous Delivery Compared to Intravenous Delivery in Rats.

  2016cites this paper
• Lymphatic system and Nanoparticulate carriers for lymphatic delivery

  2016cites this paper
• Drug Delivery to the Lymphatic System

  2016cites this paper
• Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control

  2015cites this paper
• Design of lipid-based delivery systems for improving lymphatic transport and bioavailability of delta-tocopherol and nobiletin

  2015cites this paper
• Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.

  2014cites this paper
• Nano-sized drug delivery systems for lymphatic delivery.

  2014cites this paper
• Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts.

  2013cites this paper
• Development of a new generation of drug dosage forms by construction of liposomal nanocontainers

  2012cites this paper
• Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes.

  2012cites this paper
• Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice

  2011cites this paper
• Post-lumpectomy intracavitary retention and lymph node targeting of 99mTc-encapsulated liposomes in nude rats with breast cancer xenograft

  2011cites this paper
• Liposome-coated quantum dots targeting the sentinel lymph node

  2010cites this paper
• Nano-sized Drug Carriers and Key Factors for Lymphatic Delivery

  2010cites this paper
• Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies

  2009cites this paper
• Efficient peritoneal dissemination treatment obtained by an immunostimulatory phosphorothioate-type CpG DNA/cationic liposome complex in mice.

  2008cites this paper
• Imaging of 186Re-liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis

  2008cites this paper
• Nanoparticles for targeting lymphatics

  2006cites this paper
• Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes

  2004cites this paper
• Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes

  2004cites this paper
• A Novel Approach for the Increased Delivery of Pharmaceutical Agents to Peritoneum and Associated Lymph Nodes

  2002influential citation
• Pharmacokinetics of targeting with liposomes.

  2002cites this paper
• Liposomes to target the lymphatics by subcutaneous administration.

  2001cites this paper
• Lymphatic targeting with nanoparticulate system.

  2001cites this paper
• Distribution of [3H]cholesterol-labelled liposomes with or without praziquantel in mice infected with Mesocestoides corti (Cestoda) tetrathyridia.

  2000cites this paper
• Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice

  1999influential citation
• Development of a pharmacokinetic/pharmacodynamic (PK/PD)-simulation system for doxorubicin in long circulating liposomes in mice using peritoneal P388.

  1999cites this paper
• Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes.

  1999cites this paper
• Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin.

  1997cites this paper
• Human immunoglobulin ameliorates rat experimental autoimmune neuritis.

  1997cites this paper
• Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.

  1995cites this paper
• Review of Polyclonal Antibody Production Procedures in Mammals and Poultry.

  1995cites this paper
• Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma.

  1994cites this paper
• Tissue distribution of liposomes prepared from synthetic amphiphiles after intraperitoneal injection into mice.

  1994cites this paper
• Antibody-Targeted Liposomes to Deliver Doxorubicin to Ovarian Cancer Cells

  1994cites this paper
• Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

  1993cites this paper
• In vivo gene delivery. Efficient transfection of T lymphocytes in adult mice.

  1993cites this paper
• Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes.

  1993cites this paper
• Liposomes as Carriers of Cancer Chemotherapy

  1993cites this paper
• Lymph node targeting and pharmacokinetics of [3H]methotrexate-encapsulated neutral large unilamellar vesicles and immunoliposomes

  1993cites this paper
• Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration.

  1992cites this paper
• Tissue concentrations of coenzyme Q10 in the rat following its oral and intraperitoneal administration.

  1992cites this paper
• In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.

  1992cites this paper
• Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide, in solution or bound to liposomes.

  1991cites this paper
• Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis.

  1991cites this paper
• Treatment of Tumors Using Cytostatic-containing Liposomes

  1991cites this paper
• Drug Targeting Towards the Lymphatics

  1991cites this paper
• Free and Liposomal Doxorubicin Treatment of Intraperitoneal Colon 26 Tumor: Therapeutic and Pharmacologic Studies

  1990cites this paper
• Experimental and clinical status of intraperitoneal chemotherapy.

  1990cites this paper
• Overview of chemotherapy for pancreatic cancer

  1990cites this paper
• Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastases.

  1990cites this paper
• Successful treatment using gentamicin liposomes of Salmonella dublin infections in mice

  1990cites this paper
• Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes.

  1990cites this paper
• New, simple model of mesenteric lymph node metastases in the rat

  1989cites this paper
• Catabolism of therapeutic proteins and peptides with implications for drug delivery

  1989cites this paper
• Cancer chemotherapy administered by activated carbon particles and liposomes.

  1989cites this paper
• Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.

  1988cites this paper
• The antitumour effect of lipophilic derivatives of 5-fluoro-2'-deoxyuridine incorporated into liposomes.

  1988cites this paper
• Studies on the promoting effect of lipid-surfactant mixed micelles (MM) on intestinal absorption of colloidal particles. Dependence on particle size and administration site.

  1987cites this paper
• Efficient radiolabeling of mammalian cells using 111In-tagged liposomes.

  1987cites this paper
• Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

  1986cites this paper
• The use of liposomes to study drug-membrane interactions.

  1986cites this paper
• Lymphatic Transport of Liposome-Encapsulated Drugs Following Intraperitoneal Administration – Effect of Lipid Composition

  1985cites this paper
• Peritoneal absorption of macromolecules studied by quantitative autoradiography.

  1985cites this paper
• Ocular drug bioavailability from topically applied liposomes.

  1985cites this paper
• An Approach to the Therapy of Metastases from Cancer of the Upper Rectum: A Working Hypothesis

  1985cites this paper
• Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration.

  1985cites this paper
• Liposomes as drug carriers in cancer chemotherapy.

  1984cites this paper
• Liposomes As Active Participants in Experimental Therapeutics

  1984cites this paper
• Antitumor activity of lipophilic prodrugs of mitomycin C entrapped in liposome or O/W emulsion.

  1984cites this paper
• Enhanced lymphatic delivery of mitomycin C conjugated with dextran.

  1984cites this paper
• The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.

  1984cites this paper
• Recent studies on doxorubicin and its analogues.

  1984cites this paper
• Targeting to lymphoid cells of the immune network.

  1983cites this paper
• Pharmacology of lntraperitoneal Chemotherapy

  1983cites this paper
• Absorption and tissue distribution of doxorubicin entrapped in liposomes following intravenous or intraperitoneal administration.

  1983cites this paper
• Pharmacology of intraperitoneal chemotherapy.

  1983cites this paper
• Chapter 17. Antineoplastic Agents

  1982cites this paper
• Effect of route administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat.

  1982cites this paper
• Potential applications of radionuclide-labelled liposomes in the detection of the lymphatic spread of cancer.

  1982cites this paper
• Toxicity of free and liposome-encapsulated adriamycin following large volume, short-term intraperitoneal exposure in the rat.

  1982cites this paper
• Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats.

  1982cites this paper
• Subcutaneously injected radiolabeled liposomes: transport to the lymph nodes in mice.

  1982cites this paper
• Relative muscarinic synaptic activation by anionic, neutral or cationic liposomes.

  1981cites this paper